Peter Schoen
CFO
Replay available
Bergman & Beving AB (publ) (STO: BERG_B) Q2 2025 earnings conference call, held 2025-10-22. Replay captured from the company's public earnings webcast.

CFO
CEO
Analyst, Handelsbanken
Analyst, Nordia
Analyst, Danske Bank
Welcome to the Bergman-Bevian Q2 2025 report presentation. For the first part of the presentation, participants will be in listen-only mode. During the questions and answers session, participants are able to ask questions by dialing pound key 5 on their telephone keypad. If you are listening to the presentation via webcast, you can ask written questions using the form below. Now, I will hand the conference over to speakers CEO Magnus Söderlund and CFO Peter Schoen. Please go ahead. Good morning, everyone. This is Magnus Söllen here. And on my side here, I have Peter Schoen. Good morning. So we will today present the latest financial report for the quarter ending September 30th. And as a starter, if we look at the market condition we have been facing this quarter, I would label it as we don't see any pickup in the construction nor the industry sector in the Nordics during the last months here. It hasn't gone worse, but it hasn't gone better. We have some positive sub-market that has, you know, showed some increased demand, but also we have some specific segment that still is struggling quite a lot. But despite this, we have been able to increase the earnings, the profitability, the earnings per share in the quarter if we adjust them for the non-recurring items in the quarter of 36 million crowns. And we will come back later on to explain more in details what those 36 millions include. The turnover totaled 1,127,000 SEK and the EBITDA increased 11% and we now have 23 consecutive quarters with improved profits. We also improved the margins in a quarter from 10.5 to 11.8%. That is a combination of that we have divested skydda, that typically has a lower profit margin level, in combination with acquiring high margin companies, and also that we see some margin improvement ...